BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 12, 2016
View Archived Issues
FDA grants orphan drug designation to Ovid Therapeutics' OV-101
Read More
Pivotal phase III in Tandem1 study meets primary endpoint
Read More
Vaccinex's SIGNAL study to continue
Read More
NIH dopamine D3 receptor antagonist VK-4-116 active in substance abuse models
Read More
Ligand Pharmaceuticals patents gemcitabine derivatives
Read More
Nintedanib named orphan drug in U.S. and E.U. for SSc-ILD
Read More
Acesys Pharmatech discloses antibacterial agents
Read More
FDA names cinacalcet an orphan treatment for hyperparathyroidism in children with CKD
Read More
Akari Therapeutics' coversin granted U.S. orphan status for paroxysmal nocturnal hemoglobinuria
Read More
Drug repurposing screen identifies small-molecule inhibitors of Zika virus infection
Read More
FDA grants QIDP designation to MGB-BP-3 for C. difficile-associated diarrhea
Read More
Palobiofarma describes adenosine A2B antagonists and melatonin MT3 receptor ligands
Read More
Bristol-Myers Squibb develops NS5B inhibitors
Read More
Incyte presents FGFR-4 inhibitors
Read More
Germline mutations identified in patients with atrial fibrillation and mitral valve regurgitation
Read More
Sage Therapeutics announces GABA(A) receptor modulators
Read More
Karuna initiates tolerability proof-of-concept trial for KarXT
Read More
Chiesi discloses novel compounds for pulmonary inflammation
Read More
Inflazome closes Series A financing
Read More
PC-786 shows rapid and sustained RSV replication inhibition
Read More
GSK and Aspen announce series of agreements
Read More
Phase IIIb trials to study use of dapagliflozin for chronic kidney disease and chronic heart failure
Read More
AnTolRx obtains Series A financing for targeted nanoparticle tolerance therapeutics
Read More
Takeda Pharmaceutical presents new renin inhibitor
Read More
Sanofi and Verily Life Sciences launch Onduo joint venture
Read More
BeiGene cleared to conduct clinical trials of BGB-A317 in China
Read More
Merck KGaA launches Centinel technology
Read More